Managing Partner Michael Abrams talked with MedCity News about the recent proposal by US Health and Human Services to eliminate drug kickbacks and rebates.

If administration costs are eliminated and base costs are lower as a result, this change does not need to translate into premium increases.

Read the full story at medcitynews.com